Chicago Department Of Public Health

The Chicago Department of Public Health is dedicated to promoting health and wellness across the vibrant city of Chicago. Offering a range of specialized services, the department is at the forefront of COVID-19 recovery efforts. Among their key offerings is remdesivir (Veklury), an FDA-approved treatment for COVID-19 designed for patients aged 12 and older who weigh at least 40 kg. This vital service supports the community's recovery and resilience during these challenging times.

In addition, the department provides Evusheld, a monoclonal antibody combination approved for pre-exposure prophylaxis, ensuring that those who cannot receive vaccines have a protective option. With a commitment to comprehensive care, the Chicago Department of Public Health also offers Paxlovid, a therapeutic option for COVID-19, although its authorization will conclude in March 2024. For those seeking innovative weight management solutions, their Semaglutide Injections, including Lagevrio, provide effective antiviral treatment options.

Situated in the heart of Chicago, this department stands out for its community-centric approach and dedication to public health. Their team of experienced professionals offers a warm and supportive environment, making it easier for residents to access critical health services. By prioritizing patient well-being and safety, the Chicago Department of Public Health invites the community to explore their unique offerings that contribute to a healthier, more vibrant city.